Menin inhibitor ziftomenib (KO-539) synergizes with drugs targeting chromatin regulation or apoptosis and sensitizes acute myeloid leukemia with MLL rearrangement or NPM1 mutation to venetoclax

Detalles Bibliográficos
Autores principales: Rausch, Johanna, Dzama, Margarita M., Dolgikh, Nadezda, Stiller, Hanna L., Bohl, Stephan R., Lahrmann, Catharina, Kunz, Kerstin, Kessler, Linda, Echchannaoui, Hakim, Chen, Chun-Wei, Kindler, Thomas, Döhner, Konstanze, Burrows, Francis, Theobald, Matthias, Sasca, Daniel, Kühn, Michael W. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2023
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543165/
https://www.ncbi.nlm.nih.gov/pubmed/37102614
http://dx.doi.org/10.3324/haematol.2022.282160

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543165/
https://www.ncbi.nlm.nih.gov/pubmed/37102614
http://dx.doi.org/10.3324/haematol.2022.282160

Ejemplares similares